Boston Scientific Corporation (NYSE:BSX) is included between 13 Best Low-Risk Long-Term Stocks to Buy Now

On February 5, Truist lowered its price objective on Boston Scientific Corporation (NYSE:BSX) to $95 from $120. The firm maintained a buy rating on the stock. In a note to clients, the analyst said the sharp pullback after earnings looked overdone, especially with the stock now trading at a discount to faster-growing peers.

The reaction followed the company’s earnings release on February 4, which highlighted weaker-than-expected results in the electrophysiology business. This unit, which focuses on minimally invasive treatments for heart rhythm disorders, is a key part of Boston Scientific’s growth narrative. Fourth-quarter sales for the segment came in at $890 million, below the $933 million analysts expected, according to RBC Capital Markets. The miss unnerved investors, who questioned whether the segment’s growth was losing momentum. Citi analyst Joanne Wuensch said those concerns were justified.

Sales of the Watchman device, used to help prevent strokes in patients with atrial fibrillation, also came in about 1% below forecasts. Analysts attributed the shortfall mainly to lower demand in the US market. For next year, Boston Scientific expects adjusted earnings per share of $3.43 to $3.49. The midpoint of that range landed just below Wall Street expectations of $3.47, according to LSEG data. For the quarter, revenue was $5.29 billion and adjusted earnings were 80¢ per share, both roughly in line with estimates.

Looking further ahead, the company expects organic revenue growth of 10% to 11% in 2026, which points to a slower pace compared to the 15.8% organic growth reported in 2025.

Boston Scientific Corporation (NYSE: BSX) develops and sells medical devices used in a wide range of interventional procedures worldwide.

While we recognize BSX’s potential as an investment, we believe certain AI stocks offer greater upside potential and less downside risk. If you’re looking for an extremely undervalued AI stock that will also benefit significantly from Trump-era tariffs and the onshoring trend, check out our free report on the best short term AI stock.

READ THE FOLLOWING: 15 Best Wide Moat Dividend Stocks to Invest i 12 Best HVAC Stocks to Buy Now

Disclosure: no.